Anthony B. Miller, MB, FRCP; Teresa To, PhD; Cornelia J. Baines, MD; Claus Wall, MSc
Seven- and 10-year results of the Canadian National Breast Screening Study (CNBSS) showed no reduction in breast cancer mortality from five annual mammographies and breast examinations for 40- to 49-year-old women.
Some authors have argued that longer follow-up would reveal important benefits.
After 11 to 16 years, the cumulative rate ratios for mammography versus usual care were 0.97 (95% CI, 0.74 to 1.27) for breast cancer mortality without adjustment for nonstudy mammography and 1.06 (CI, 0.80 to 1.40) with adjustment.
The CNBSS suggests that screening 40- to 49-year-old women is unlikely to reduce breast cancer by 20% or more.
Controversy will persist because other studies suggest that screening causes small reductions in breast cancer mortality.
Appendix Table 1.
Appendix Table 2.
Appendix Table 3.
Appendix Table 4.
Miller AB, To T, Baines CJ, et al. The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years. Ann Intern Med. 2002;137:305–312. doi: https://doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00005
Download citation file:
Published: Ann Intern Med. 2002;137(5_Part_1):305-312.
Breast Cancer, Hematology/Oncology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use